Journals / Türk Biyokimya Dergisi / 2018 / Cilt: 43 - Sayı: 5

Evaluation of Gas6 and sAxl levels during attacks and attack-free periods of familial Mediterranean fever

Ailesel Akdeniz ateşinin atak ve remisyon dönemlerinde Gas6 ve sAxl düzeylerinin değerlendirilmesi

Pages
475–480
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies on the role of the Gas6/Axl systemin FMF are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We aimed to assess the growth arrest specificprotein 6 (Gas6) and soluble Axl (sAxl) levels in the familialMediterranean fever (FMF) patients, and to investigatethe correlation between the levels of these with theinflammatory markers including C-reactive protein (CRP),erythrocyte sedimentation rate (ESR) and fibrinogen.Materials and methods: Seventy nine FMF patients (35 inattack period and 44 in attack-free period) and 40 healthycontrols were involved in the study.
📊
Key Findings & Data:The levels of serumGas6 and sAxl were measured by enzyme-linked immunosorbentassay (ELISA) method.Results: Gas6 levels of the FMF patients with attack weresignificantly lower than both the attack-free patients andthe healthy controls (p = 0.007 and p = 0.003, respectively).However, no significant difference was detected betweenthe Gas6 levels of the attack-free patients and the healthycontrols (p > 0.05). sAxl levels of the FMF patients withattack were significantly lower than the healthy control(p = 0.007).
💡
Conclusion & Impact:Further studies on the role of the Gas6/Axl systemin FMF are needed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We aimed to assess the growth arrest specificprotein 6 (Gas6) and soluble Axl (sAxl) levels in the familialMediterranean fever (FMF) patients, and to investigatethe correlation between the levels of these with theinflammatory markers including C-reactive protein (CRP),erythrocyte sedimentation rate (ESR) and fibrinogen.Materials and methods: Seventy nine FMF patients (35 inattack period and 44 in attack-free period) and 40 healthycontrols were involved in the study. The levels of serumGas6 and sAxl were measured by enzyme-linked immunosorbentassay (ELISA) method.Results: Gas6 levels of the FMF patients with attack weresignificantly lower than both the attack-free patients andthe healthy controls (p = 0.007 and p = 0.003, respectively).However, no significant difference was detected betweenthe Gas6 levels of the attack-free patients and the healthycontrols (p > 0.05). sAxl levels of the FMF patients withattack were significantly lower than the healthy control(p = 0.007). A positive correlation was found betweenthe Gas6 and CRP levels of the FMF patients with attack(r = 0.379, p = 0.025).Conclusions: This study indicates that decreased serumGas6 and sAxl levels may be associated with FMF attackperiod. Further studies on the role of the Gas6/Axl systemin FMF are needed.

Özet

Amaç: Bu çalışmada, Ailesel Akdeniz ateşi (AAA) hastalarında büyüme durdurucu spesifik protein 6 (Gas6) ve çözünür Axl (sAxl) düzeylerini değerlendirmeyi ve bunların C-reaktif protein (CRP), eritrosit sedimantasyon hızı (ESR) ve fibrinojen gibi inflamatuar belirteçlerle ilişkisini araştırmayı amaçladık. Gereç ve Yöntem: Çalışmaya 79 AAA’lı hasta (atak döneminde 35, remisyon döneminde 44) ve 40 sağlıklı birey dahil edildi. Serum Gas6 ve sAxl seviyeleri enzim bağlı immün assay (ELISA) yöntemi ile ölçüldü. Bulgular: Atak döneminde olan AAA’lı hastalarda Gas6 düzeyleri hem remisyon döneminde olan hastalardan hemde sağlıklı kontrollerden anlamlı derecede düşüktü (sırasıyla, p = 0.007 ve p = 0.003). Bununla birlikte, remisyon döneminde olan hastalar ile sağlıklı kontroller arasında anlamlı farklılık saptanmadı (p > 0.05). Atak döneminde olan hastalarda sAxl düzeyleri sağlıklı kontrol grubundan anlamlı derecede düşüktü (p = 0.007). Atak döneminde olan hastalarda, Gas6 düzeyi ile CRP düzeyi arasında pozitif korelasyon bulundu (r = 0.379, p = 0.025). Sonuç: Bu çalışma, azalmış serum Gas6 ve sAxl düzeylerinin AAA atak dönemi ile ilişkili olabileceğini göstermektedir. AAA‘da, Gas6/Axl sisteminin rolü üzerine daha ileri çalışmalara ihtiyaç vardır.

🔖

Cite This Article

ÇELİK, M. M., ÇAKIRCA, G. (2022). Evaluation of Gas6 and sAxl levels during attacks and attack-free periods of familial Mediterranean fever. Türk Biyokimya Dergisi, Cilt: 43 - Sayı: 5, 475–480. https://ajindex.com/articles/620969

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the world. Arthritis Rheum 2009;61:1447–53
  2. Onen F. Familial Mediterranean fever. Rheumatol Int 2006;26:489–96
  3. Fonnesu C, Cerquaglia C, Giovinale M, Curigliano V, Verrecchia E, de Socio G, et al. Familial Mediterranean fever: a review for clinical management. Joint Bone Spine 2009;76:227–33
  4. Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C, et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000;95:3223–31
  5. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003;11:591–604
  6. Tunca M, Ben-Chetrit E. Familial Mediterranean fever in 2003. Pathogenesis and management. Clin Exp Rheumatol 2003; 21(4 Suppl 30):S49–52
  7. Hafizi S, Dahlback B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 2006;273:5231–44
  8. Korshunov VA. Axl-dependent signalling: a clinical update. Clin Sci 2012;122:361–8
  9. Jung JY, Suh CH. Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker. Int J Rheum Dis 2015;18:294–303
  10. Ekman C, Stenhoff J, Dahlback B. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost 2010;8:838–44
  11. Axelrod H, Pienta KJ. Axl as a mediator of cellular growth and survival. Oncotarget 2014;5:8818–52
  12. Rothlin CV, Lemke G. TAM receptor signaling and autoimmune disease. Curr Opin Immunol 2010;22:740–6
  13. Hurtado B, de Frutos PG. GAS6 in systemic inflammatory diseases: with and without infection. Crit Care 2010;14:1003
  14. Linger RM, Keating AK, Earp HS, Graham DK. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 2008;100:35–83
  15. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879–85
  16. Lee IJ, Hilliard B, Swami A, Madara JC, Rao S, Patel T, et al. Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure. Nephrol Dial Transplant 2012;27:4166–72
  17. Jiang L, Liu CY, Yang QF, Wang P, Zhang W. Plasma level of growth arrest-specific 6 (GAS6) prot